MediXall Group Statistics
Total Valuation
MediXall Group has a market cap or net worth of 851,904. The enterprise value is 4.68 million.
| Market Cap | 851,904 |
| Enterprise Value | 4.68M |
Important Dates
The last earnings date was Thursday, April 17, 2025.
| Earnings Date | Apr 17, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MediXall Group has 218.44 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 218.44M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 2.17% |
| Owned by Institutions (%) | 3.61% |
| Float | 201.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.75 |
| PB Ratio | -0.13 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.96 |
| EV / Sales | 15.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.00
| Current Ratio | 0.00 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.05 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -460.46% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 60.03% |
| Revenue Per Employee | 44,203 |
| Profits Per Employee | -696,687 |
| Employee Count | 7 |
| Asset Turnover | 0.58 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +389,900.00% in the last 52 weeks. The beta is 29.40, so MediXall Group's price volatility has been higher than the market average.
| Beta (5Y) | 29.40 |
| 52-Week Price Change | +389,900.00% |
| 50-Day Moving Average | 0.34 |
| 200-Day Moving Average | 1.09 |
| Relative Strength Index (RSI) | 41.08 |
| Average Volume (20 Days) | 10,691 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, MediXall Group had revenue of 309,422 and -4.88 million in losses. Loss per share was -0.04.
| Revenue | 309,422 |
| Gross Profit | -932,300 |
| Operating Income | -3.92M |
| Pretax Income | -4.56M |
| Net Income | -4.88M |
| EBITDA | -3.88M |
| EBIT | -3.92M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 10,721 in cash and 3.83 million in debt, giving a net cash position of -3.82 million or -0.02 per share.
| Cash & Cash Equivalents | 10,721 |
| Total Debt | 3.83M |
| Net Cash | -3.82M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | -6.52M |
| Book Value Per Share | -0.05 |
| Working Capital | -6.71M |
Cash Flow
| Operating Cash Flow | -1.23M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -1,265.64% |
| Pretax Margin | -1,474.82% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MediXall Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.00% |
| Shareholder Yield | -9.00% |
| Earnings Yield | -572.46% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MediXall Group has an Altman Z-Score of -358.14. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -358.14 |
| Piotroski F-Score | n/a |